DAA1020 |
Heart disease (Male) |
Pathological |
heart |
Human |
— |
SeriesIncidence |
|
DAA625 |
Heart failure |
Pathological |
heart |
Human |
— |
SeriesMorbidity |
|
DAA711 |
Heart physiology measurements unchanged |
Physiological |
heart |
Human |
— |
— |
|
DAA712 |
Heart physiology parameters altered |
Physiological |
heart |
Human |
— |
— |
|
DAA438 |
heat shock 70kDa protein 1A |
Molecular |
skeletal muscle |
Human |
HSPA1A |
4.0% Increase Gene Expression Level |
|
DAA104 |
heat shock 70kDa protein 8 |
Molecular |
brain |
Human |
HSPA8 |
7.0% Decrease Gene Expression Level |
|
DAA1773 |
heat shock factor binding protein 1 |
Molecular |
muscle |
Mouse |
Hsbp1 |
2.0% Decrease Gene Expression Level |
|
DAA1918 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
Molecular |
Anatomical System |
Mouse |
Hsp90aa1 |
1.0% Decrease Gene Expression Level |
|
DAA105 |
heat shock protein 90kDa alpha (cytosolic), class B member 1 |
Molecular |
brain |
Human |
HSP90AB1 |
5.0% Decrease Gene Expression Level |
|
DAA547 |
heat shock transcription factor 1 |
Molecular |
skeletal muscle |
Human |
HSF1 |
5.0% Decrease Gene Expression Level |
|
DAA1258 |
heat shock transcription factor, Y linked 2 |
Molecular |
brain |
Mouse |
Hsfy2 |
81.0% Decrease Gene Expression Level |
|
DAA343 |
hematological and neurological expressed 1 |
Molecular |
skeletal muscle |
Human |
HN1 |
3.0% Increase Gene Expression Level |
|
DAA1991 |
Hematopoietic cells accumulate random mutations |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA103 |
hepatic leukemia factor |
Molecular |
brain |
Human |
HLF |
10.0% Decrease Gene Expression Level |
|
DAA576 |
hepsin |
Molecular |
skeletal muscle |
Human |
HPN |
4.0% Increase Gene Expression Level |
|
DAA399 |
heterogeneous nuclear ribonucleoprotein A1 |
Molecular |
skeletal muscle |
Human |
HNRNPA1 |
2.0% Increase Gene Expression Level |
|
DAA496 |
heterogeneous nuclear ribonucleoprotein A3 |
Molecular |
skeletal muscle |
Human |
HNRNPA3 |
3.0% Increase Gene Expression Level |
|
DAA539 |
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
Molecular |
skeletal muscle |
Human |
HNRNPC |
3.0% Increase Gene Expression Level |
|
DAA473 |
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) |
Molecular |
skeletal muscle |
Human |
HNRNPD |
2.0% Increase Gene Expression Level |
|
DAA405 |
heterogeneous nuclear ribonucleoprotein M |
Molecular |
skeletal muscle |
Human |
HNRNPM |
4.0% Increase Gene Expression Level |
|
DAA1215 |
Higher adrenocroticotropic hormone levels |
Physiological |
plasma |
Human |
POMC |
— |
|
DAA877 |
Higher oxidation and decreased proteasome activity |
Molecular |
epidermis |
Human |
— |
— |
|
DAA418 |
high-mobility group nucleosomal binding domain 2 |
Molecular |
skeletal muscle |
Human |
HMGN2 |
3.0% Increase Gene Expression Level |
|
DAA655 |
Hip fracture risk increases |
Pathological |
femur |
Human |
— |
— |
|
DAA102 |
histidine triad nucleotide binding protein 1 |
Molecular |
brain |
Human |
HINT1 |
5.0% Decrease Gene Expression Level |
|